Value Hunters: Look To Akero Therapeutics Inc (AKRO)
Currently, there are 69.61M common shares owned by the public and among those 58.32M shares have been available to trade. The company’s stock has a 5-day price change of 105.69% and 80.36% over the past three months. AKRO shares are trading 85.87% year to date (YTD), with the 12-month market performance up to 136.44% higher. […]
Look At Analyst Expectations For A Better Read On Akero Therapeutics Inc (NASDAQ: AKRO)
Currently, there are 69.61M common shares owned by the public and among those 58.30M shares have been available to trade. The company’s stock has a 5-day price change of -1.94% and -3.50% over the past three months. AKRO shares are trading 19.14% year to date (YTD), with the 12-month market performance up to 19.14% higher. […]
Akero Therapeutics Inc (AKRO): A Great Stock For Handling Current Market Conditions?
Currently, there are 55.71M common shares owned by the public and among those 50.08M shares have been available to trade. Insiders at the company have transacted a total of 73 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 20 of these insider trades were purchases, […]
